abstract |
The present invention relates to biphenylene lactams of Formula (II) which are ligands at the prostaglandin receptors, as well as a method for treating prostaglandin mediated diseases comprising administration to a patient in need of such a treatment of a non-toxic therapeutically effective amount of compound of Formula (II), and the like. |